In Q2 fiscal 2026 (the quarter ended June 30, 2026), GE HealthCare Technologies's largest business segment was AIS, with $3.77 billion or 71% of revenue, up 8.0% from a year earlier. Next: PDx (16%) and PCS (13%).
By product or service, Product brought in 65% and Service brought in 35% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was PDx (+15.6%).
From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q1 fiscal 2022.

Fiscal quarters, from company filings
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| AIS | $3.8B | – | – | $3.5B | 71% |
| PDx | $843.0M | $770.0M | $749.0M | $729.0M | 16% |
| PCS | $675.0M | $704.0M | $731.0M | $778.0M | 13% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Product | $3.4B | $3.3B | $3.4B | $3.3B | 65% |
| Service | $1.9B | $1.8B | $1.8B | $1.7B | 35% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
AIS, PDx and PCS (as reported for Q2 fiscal 2026).
AIS: $3.77 billion, or 71% of revenue, in Q2 fiscal 2026.
By revenue in Q2 fiscal 2026: Product (65%) and Service (35%).
Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i
Fiscal quarter ended Jun 30, 2026
| Item | Revenue | Share |
|---|---|---|
| Ais | USD 3.77B | 71.3% |
| PDx | USD 843.00M | 15.9% |
| Pcs | USD 675.00M | 12.8% |
| Corporate and otheri | USD 6.00M |
Sum of items USD 5.29B; corporate items and eliminations USD 6.00M. Shares are of the items shown. Click an item with › to see its parts.
Every item and period in one grid. Purple = calculated; "–" = not available.
| Item | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q4 FY23 | Q3 FY23 | Q2 FY23 | Q1 FY23 | Q4 FY22 | Q3 FY22 | Q2 FY22 | Q1 FY22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imaging | – | 2.3B | 2.6B | 2.3B | – | 2.1B | 2.4B | 2.2B | 2.2B | 2.1B | 2.8B | 2.2B | 2.6B | 2.5B | 2.7B | 2.5B | 2.4B | 2.3B |
| Pcs | 675.0M | 704.0M | 824.0M | 731.0M | 778.0M | 753.0M | 827.0M | 779.0M | 772.0M | 747.0M | 827.0M | 764.0M | 770.0M | 781.0M | 786.0M | 701.0M | 713.0M | 716.0M |
| Avs | – | 1.3B | 1.5B | 1.3B | – | 1.2B | 1.4B | 1.2B | 1.2B | 1.2B | – | 1.2B | – | – | – | – | – | – |
| PDx | 843.0M | 770.0M | 790.0M | 749.0M | 729.0M | 632.0M | 645.0M | 625.0M | 639.0M | 599.0M | 591.0M | 589.0M | 568.0M | 558.0M | 473.0M | 522.0M | 478.0M | 484.0M |
| Ais | 3.8B | – | – | – | 3.5B | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Ultrasound | – | – | – | – | – | – | – | – | – | – | 944.0M | – | 839.0M | 859.0M | 956.0M | 823.0M | 828.0M | 815.0M |
| Corporate and other | 6.0M | 18.0M | 6.0M | 15.0M | 6.0M | 13.0M | 13.0M | 15.0M | 9.0M | 15.0M | 14.0M | 19.0M | 20.0M | 13.0M | 13.0M | 14.0M | 16.0M | 17.0M |